Market Value2,135,928,483
Total Holdings30
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
VOR / Vor Biopharma Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ACLX / Arcellx, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
AMAM / Ambrx Biopharma Inc. Call
XENE / Xenon Pharmaceuticals Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
IMTX / Immatics N.V.
NUVL / Nuvalent, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
AVTE / Aerovate Therapeutics, Inc.
INCY / Incyte Corporation
TGTX / TG Therapeutics, Inc.
AMAM / Ambrx Biopharma Inc. Call
ROIV / Roivant Sciences Ltd.
AMAM / Ambrx Biopharma Inc.
UTHR / United Therapeutics Corporation
ETNB / 89bio, Inc. Call
SNDX / Syndax Pharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
ARVN / Arvinas, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
AMAM / Ambrx Biopharma Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
CERE / Cerevel Therapeutics Holdings, Inc.
COGT / Cogent Biosciences, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
CRGX / CARGO Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
IRON / Disc Medicine, Inc.
KURA / Kura Oncology, Inc.
ALPN / Alpine Immune Sciences, Inc.
CRBU / Caribou Biosciences, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.